A CLINICAL STUDY TO EVALUATE THE ROLE OF SHIVAGUTIKA IN PELVIC INFLAMMATORY DISEASE
Background: Pelvic Inflammatory Disease is an infective condition of genital tract with symptoms like lower abdominal pain and tenderness, abnormal vaginal discharge, chills, and fever. Various yonivyapaths (Diseases of the female reproductive system), presenting the above said symptoms like adhodara shoola (Lower abdominal pain), shoola in maithuna (dyspareunia), jwara (fever) and yonisrava (discharge per vagina) include vatala (endometriosis), paripluta (pelvic inflammatory disease), mahayoni (genital organ prolapse) and so on.
Aims and objectives: To evaluate the effect of an shivagutika in PID subjects with an intention to maximize its clinical effectiveness and hasten its integration into wider clinical practice.
Materials and methods: Shivagutika was administered twice daily with honey after food intake for 60 days. The signs and symptoms of PID were graded before and during the course of treatment. In most of the cases, there was a progressive reduction in the symptoms with time, indicating the efficacy of the formulation in PID.
Conclusion: Shiva gutika efficiently decreases the symptoms of PID, clinically controls infection and can be recommended in the management of Pelvic Inflammatory Disease.
D. Keith Edmonds. Dewhurts Textbook of Gyneacology. 7th ed. Massachusetts,USA: Blackwell Publishing:2007.p.1428.
Emans S.J., Laufer R.L., Goldstein, D.P. Pediatric & adolescent gynecology. 5thed. Philadelphia: Lippincott Williams & Wilkins: 2007.p.1362.
Joshi N.G. Ayurvedic Concepts in Gynaecology. Jawahar Nagar. New Delhi: Chaukhamba Sanskrit Pratishthan: 1999.p.76.
B.S. Sengupta, S.K. Chattopadhyaya. D.C. Dutta. Gynaecology for Postgraduates & Practitioners.Culcutta: B.I. Churchill Livingstone Pvt Ltd:2006.p.213.
J.P. Tripathi, editor, Chakradatta with Bhavartha Sandipani Commentary of Chakrapanidatta. Varanasi: Chaukhambha Sanskrit Series;2003.p.218.
Patient Information Leaflet for PID–Royal College of Obstetrics and Gynaecologists.
Acharya SB, Frotan MH, Goel RK, Tripathi SK, Das PK. Pharmacological actions of Shilajit. Indian Journal of Experimental Biology. 1988; 26: 775–777.
Bhaumik S, Chattapadhay S, Ghosal S. Effects of Shilajit on mouse peritoneal macrophages. Phytotherapy Research. 1993; 7: 425–427.
Bhattacharya SK. Shilajit attenuates streptozotocin induced diabetes mellitus and decrease in pancreatic islet superoxide dismutase activity in rats. Phytotherapy Research. 1995; 9(1): 41-44
Velmurugan Vivek. et al. Immunomodulatory activities of the aqueous extracts of some Indian medicinal plants. Journal of Pharmaceutical and Biomedical Sciences (JPBMS). 2010; 1 (01), 347-50.
Trivedi NA, Mazumdar B, Bhatt JD, Hemavathi KG. Effect of shilajit on blood glucose and lipid profile in alloxan-induced diabetic rats. Indian Journal of Pharmacology. 2004;36:373-6
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.